Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars

Zinger Key Points
  • Organigram reported Q4 sales of $31.22 million, with adjusted EBITDA rising to C$5.9 million from C$0.1 million last year.
  • Net loss improved to C$5.4 million from C$26.6 millionYoY, driven by higher gross margins and reduced impairment losses.

On Wednesday, Cannabis producer Organigram Holdings Inc OGI reported fourth-quarter sales of $31.22 million (44.7 million Canadian dollars), up from 36.7 million Canadian dollars, beating the consensus of 42.98 million Canadian dollars.

The company adds it became Canada’s largest cannabis company by market share following the acquisition of Motif Labs subsequent to year-end.

Also Read: Organigram Wants To Become Canada’s Largest Cannabis Company By Market Share Via $71M Acquisition Deal

Sales increased 22% year-over-year, primarily due to higher recreational cannabis sales and international sales.

Adjusted gross margin was 16.5 million Canadian dollars, or 37% of net revenue, compared to 7.2 million Canadian dollars, or 20%, compared to last year due to efficiency increases across cultivation, manufacturing, and distribution and higher recreational and international sales.

Adjusted EBITDA was 5.9 million Canadian dollars compared to 0.1 million a year ago, primarily attributable to higher net flower revenue, lower general and administrative expenses, and increased gross margins.

The net loss was 5.4 million Canadian dollars, compared to 26.6 million a year ago, primarily due to higher adjusted gross margins and lower impairment losses in the current quarter.

“We are pleased with the growth we achieved every quarter in Fiscal 2024, ending the year on a high note with respect to net revenue and adjusted EBITDA,” said Greg Guyatt, Chief Financial Officer.

“Efficiency improvements in our operations supported our strong adjusted gross margin in the quarter. Our operational improvements, combined with our recent acquisition of Motif, has laid the foundation for continued growth in Fiscal 2025,” Guyatt added.

Organigram expects sufficient liquidity to meet strategic and operational objectives in fiscal 2025. The company realized C$9.1 million in annual cost savings through extensive efficiency initiatives in Fiscal 2024.

Price Action: At last check on Wednesday, OGI stock was up 9.32% at $1.76 during the premarket session.

Read Next:

Photo: Courtesy of Hvoenok and GOR Photo on Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.